Terms: = Brain cancer AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB AND Treatment
50 results:
1. Identification of core genes of craniopharyngioma angiogenesis based on single-cell nuclear transcriptome sequencing.
Zhang J; Xu L; Ye J; Xu C; Wu B; Wu J; Hong T
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):136-141. PubMed ID: 38650143
[TBL] [Abstract] [Full Text] [Related]
2. Investigation of iso-propylchaetominine anticancer activity on apoptosis, cell cycle and Wnt signaling pathway in different cancer models.
Karamad V; Sogutlu F; Ozkaya FC; Shademan B; Ebrahim W; El-Neketi M; Avci CB
Fitoterapia; 2024 Mar; 173():105789. PubMed ID: 38158162
[TBL] [Abstract] [Full Text] [Related]
3. Craniopharyngioma in Pediatrics and Adults.
Piloni M; Gagliardi F; Bailo M; Losa M; Boari N; Spina A; Mortini P
Adv Exp Med Biol; 2023; 1405():299-329. PubMed ID: 37452943
[TBL] [Abstract] [Full Text] [Related]
4. Craniopharyngioma-An update on metabolic and cognitive complications and new therapy.
Erfurth EM
J Intern Med; 2023 Sep; 294(3):269-280. PubMed ID: 37424210
[TBL] [Abstract] [Full Text] [Related]
5. Endometrioid Adenocarcinoma Resembling Cutaneous Pilomatrix Carcinoma: A Case Report of an Aggressive Neoplasm in a Young Woman With Diffusely Aberrant Beta-catenin Expression and Associated Morular Metaplasia and Atypical Polypoid Adenomyoma-type Change.
Keane E; Floyd R; McDonnell C; Beirne JP; Ó'Riain C; Komanyane L
Int J Gynecol Pathol; 2023 Sep; 42(5):466-471. PubMed ID: 36811845
[TBL] [Abstract] [Full Text] [Related]
6. Contemporary Biological Insights and Clinical Management of Craniopharyngioma.
Apps JR; Muller HL; Hankinson TC; Yock TI; Martinez-Barbera JP
Endocr Rev; 2023 May; 44(3):518-538. PubMed ID: 36574377
[TBL] [Abstract] [Full Text] [Related]
7. Molecular Stratification of Medulloblastoma: Clinical Outcomes and Therapeutic Interventions.
Sursal T; Ronecker JS; Dicpinigaitis AJ; Mohan AL; Tobias ME; Gandhi CD; Jhanwar-Uniyal M
Anticancer Res; 2022 May; 42(5):2225-2239. PubMed ID: 35489737
[TBL] [Abstract] [Full Text] [Related]
8. Targeted Therapy in the Management of Modern Craniopharyngiomas.
Reyes M; Taghvaei M; Yu S; Sathe A; Collopy S; Prashant GN; Evans JJ; Karsy M
Front Biosci (Landmark Ed); 2022 Apr; 27(4):136. PubMed ID: 35468695
[TBL] [Abstract] [Full Text] [Related]
9. Targeted therapies in the medical management of craniopharyngioma.
Iglesias P
Pituitary; 2022 Jun; 25(3):383-392. PubMed ID: 35301645
[TBL] [Abstract] [Full Text] [Related]
10. Whole-Genome and Transcriptome Sequencing Identified NOTCH2 and HES1 as Potential Markers of Response to Imatinib in Desmoid Tumor (Aggressive Fibromatosis): A Phase II Trial Study.
Kwon J; Lee JH; Lee YH; Lee J; Ahn JH; Kim SH; Kim SH; Kim TI; Yun KH; Park YS; Kim JE; Lee KS; Choi JK; Kim HS
Cancer Res Treat; 2022 Oct; 54(4):1240-1255. PubMed ID: 35038826
[TBL] [Abstract] [Full Text] [Related]
11. Impact of Tumor Suppressor Gene Co-Mutations on Differential Response to EGFR TKI Therapy in EGFR L858R and Exon 19 Deletion Lung cancer.
Hellyer JA; White MN; Gardner RM; Cunanan K; Padda SK; Das M; Ramchandran K; Neal JW; Wakelee HA
Clin Lung Cancer; 2022 May; 23(3):264-272. PubMed ID: 34838441
[TBL] [Abstract] [Full Text] [Related]
12. Recurrent Wnt medulloblastoma treated with marrow-ablative chemotherapy and autologous hematopoietic progenitor cell rescue: a dual case report and review of the literature.
Harris MK; Shatara M; Funk Z; Stanek J; Boué DR; Jones J; Finlay JL; Abdelbaki MS
Childs Nerv Syst; 2022 Feb; 38(2):465-472. PubMed ID: 33948723
[TBL] [Abstract] [Full Text] [Related]
13. Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).
Gajjar A; Robinson GW; Smith KS; Lin T; Merchant TE; Chintagumpala M; Mahajan A; Su J; Bouffet E; Bartels U; Schechter T; Hassall T; Robertson T; Nicholls W; Gururangan S; Schroeder K; Sullivan M; Wheeler G; Hansford JR; Kellie SJ; McCowage G; Cohn R; Fisher MJ; Krasin MJ; Stewart CF; Broniscer A; Buchhalter I; Tatevossian RG; Orr BA; Neale G; Klimo P; Boop F; Srinivasan A; Pfister SM; Gilbertson RJ; Onar-Thomas A; Ellison DW; Northcott PA
J Clin Oncol; 2021 Mar; 39(7):822-835. PubMed ID: 33405951
[TBL] [Abstract] [Full Text] [Related]
14. Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR Libraries.
Rocha CRR; Reily Rocha A; Molina Silva M; Rodrigues Gomes L; Teatin Latancia M; Andrade Tomaz M; de Souza I; Karolynne Seregni Monteiro L; Menck CFM
Cells; 2020 Dec; 9(12):. PubMed ID: 33271924
[TBL] [Abstract] [Full Text] [Related]
15. Integrated Proteogenomic Characterization across Major Histological Types of Pediatric brain cancer.
Petralia F; Tignor N; Reva B; Koptyra M; Chowdhury S; Rykunov D; Krek A; Ma W; Zhu Y; Ji J; Calinawan A; Whiteaker JR; Colaprico A; Stathias V; Omelchenko T; Song X; Raman P; Guo Y; Brown MA; Ivey RG; Szpyt J; Guha Thakurta S; Gritsenko MA; Weitz KK; Lopez G; Kalayci S; Gümüş ZH; Yoo S; da Veiga Leprevost F; Chang HY; Krug K; Katsnelson L; Wang Y; Kennedy JJ; Voytovich UJ; Zhao L; Gaonkar KS; Ennis BM; Zhang B; Baubet V; Tauhid L; Lilly JV; Mason JL; Farrow B; Young N; Leary S; Moon J; Petyuk VA; Nazarian J; Adappa ND; Palmer JN; Lober RM; Rivero-Hinojosa S; Wang LB; Wang JM; Broberg M; Chu RK; Moore RJ; Monroe ME; Zhao R; Smith RD; Zhu J; Robles AI; Mesri M; Boja E; Hiltke T; Rodriguez H; Zhang B; Schadt EE; Mani DR; Ding L; Iavarone A; Wiznerowicz M; Schürer S; Chen XS; Heath AP; Rokita JL; Nesvizhskii AI; Fenyö D; Rodland KD; Liu T; Gygi SP; Paulovich AG; Resnick AC; Storm PB; Rood BR; Wang P; ;
Cell; 2020 Dec; 183(7):1962-1985.e31. PubMed ID: 33242424
[TBL] [Abstract] [Full Text] [Related]
16. Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with
Ortiz-Cuaran S; Mezquita L; Swalduz A; Aldea M; Mazieres J; Leonce C; Jovelet C; Pradines A; Avrillon V; Chumbi Flores WR; Lacroix L; Loriot Y; Westeel V; Ngo-Camus M; Tissot C; Raynaud C; Gervais R; Brain E; Monnet I; Giroux Leprieur E; Caramella C; Mahier-Aït Oukhatar C; Hoog-Labouret N; de Kievit F; Howarth K; Morris C; Green E; Friboulet L; Chabaud S; Guichou JF; Perol M; Besse B; Blay JY; Saintigny P; Planchard D
Clin Cancer Res; 2020 Dec; 26(23):6242-6253. PubMed ID: 32859654
[TBL] [Abstract] [Full Text] [Related]
17. Proteins of Wnt signaling pathway in cancer stem cells of human glioblastoma.
Shevchenko V; Arnotskaya N; Zaitsev S; Sharma A; Sharma HS; Bryukhovetskiy A; Pak O; Khotimchenko Y; Bryukhovetskiy I
Int Rev Neurobiol; 2020; 151():185-200. PubMed ID: 32448607
[TBL] [Abstract] [Full Text] [Related]
18. miR-150-5p suppresses the stem cell-like characteristics of glioma cells by targeting the Wnt/β-catenin signaling pathway.
Tian W; Zhu W; Jiang J
Cell Biol Int; 2020 May; 44(5):1156-1167. PubMed ID: 32009256
[TBL] [Abstract] [Full Text] [Related]
19. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
[TBL] [Abstract] [Full Text] [Related]
20. Adamantinomatous craniopharyngioma: moving toward targeted therapies.
Hengartner AC; Prince E; Vijmasi T; Hankinson TC
Neurosurg Focus; 2020 Jan; 48(1):E7. PubMed ID: 31896087
[TBL] [Abstract] [Full Text] [Related]
[Next]